Facebook
X
LinkedIn
ForwardJPS Pharmacy: FY27 Anticoagulation After Heart Valve Replacement: Review of The New Evidence
Target Audience
Clinical pharmacists at JPS Health Network
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Compare anticoagulation recommendations across prosthetic heart valve types;
- Review key clinical trials influencing anticoagulation after heart valve replacement; and
- Apply current evidence to optimize antithrombotic therapy in patients with prosthetic heart valves.
Course summary
- 1.00 ACPE Pharmacy
- 1.00 HSC Participation
In support of improving patient care, this activity has been planned and implemented by The University of North Texas Health Science Center at Fort Worth and JPS Health Network. The University of North Texas Health Science Center at Fort Worth is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing Education for the healthcare team.
Designations
Pharmacist
This knowledge-based activity has been assigned UAN JA0004637-9999-26-035-L99-P and will award 1 contact hour of continuing pharmacy education credit in states that recognized ACPE Providers.
Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity and requesting credit online at the conclusion of the activity.
Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. HSC complies with the Accreditation Standards for Continuing Pharmacy Education.
Certificate of Attendance
The University of North Texas Health Science Center at Fort Worth certifies this activity for 1.0 hour of participation.
Available Credit
- 1.00 ACPE Pharmacy
- 1.00 HSC Participation